We have developed plasmid-based expression systems that encode modifie
d forms of T7 RNA polymerase (RNAP) having 6-12 histidine residues fus
ed to the amino terminus. The histidine-tagged RNAPs (His-T7 RNAPS) ar
e indistinguishable from the wild-type (WT) enzyme in nearly all bioch
emical assays. Similar plasmids that encode His-tagged T3 and SP6 RNAP
s have also been constructed. To facilitate site-directed mutagenesis
of the RNAP gene, the size of the target plasmid was minimized by usin
g T7 RNAP itself as a selectable marker. BL21 (DCAT4) cells (which car
ry a chromosomal copy of the chloramphenicol acetyl-transferase cat ge
ne under control of a T7 promoter) are resistant to chloramphenicol wh
en functional T7 RNAP is expressed, thus allowing the selection and ma
intenance of the target plasmid in these cells. Mutagenesis is accompl
ished by denaturing the plasmid, annealing mutagenic DNA primers, and
repairing the plasmid with T4 DNA polymerase. Two DNA primers are used
: one corrects a defect in the bla gene, the other introduces the desi
red mutation into the RNAP gene; 30-85% of the ampicillin-resistant tr
ansformants carry the desired mutation in the RNAP gene. By using BL21
(DCAT4) cells as a recipient for transformation the functional integr
ity of the RNAP gene may conveniently be monitored by assessing the le
vel of chloramphenicol resistance in vivo. Methods for rapid, simultan
eous purification of multiple samples of modified (His-tagged) and con
ventional RNAPs are described. Together, these developments greatly en
hance our ability to characterize this important class of enzymes. (C)
1997 Academic Press.